首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Pharmacokinetics, tissue distribution and excretion of saponins after intravenous administration of ShenMai Injection in rats
【24h】

Pharmacokinetics, tissue distribution and excretion of saponins after intravenous administration of ShenMai Injection in rats

机译:静脉施氮后静脉施氮后皂苷的药代动力学,组织分布及排泄

获取原文
获取原文并翻译 | 示例
           

摘要

ShenMai Injection (SMI) is a traditional Chinese medicine that has been extensively applied in the treatment of coronary artery disease and tumor for many years. However, there is still lack of deep research on the behaviors of SMI in vivo. In this study, a reliable, specific, and sensitive method was developed for simultaneous determination of sixteen saponins found in SMI using liquid chromatography tandem mass spectrometry (LC-MS/MS). This method was successfully applied to investigate the pharmacokinetics, tissue distribution and excretion of sixteen active compounds after a single intravenous administration of SMI. These compounds included seven protopapaxdiol (PPD-type) ginsenosides (ginsenosides Rb-1, Rb-2, Rb-3, Rc, Rd, S-Rg(3), R-Rg(3)), six protopapaxtriol (PPT-type) ginsenosides (notoginsenoside R-1, ginsenosides Re, Rf, Rg(1), S-Rg(2), R-Rg(2)), one oleanolic acid type ginsenoside (ginsenoside Ro) and two ophiopogonins (ophiopogonin D (MD-D) and ophiopogonin D' (MD-D')). Connection of the C-20 hydroxyl group to the glycoside and the chiral configuration of C-20 might significantly impact the pharmacokinetic behaviors in vivo of ginsenosides, particularly PPD-type ginsenosides. PPD-type ginsenosides were usually eliminated slowly in serum and tissues, but S/R-Rg(3) bearing a free hydroxyl group at C-20 exhibited quick elimination, and R-Rg(3) underwent quicker elimination than S-Rg(3). The PPT-type ginsenosides, oleanolic acid type ginsenoside and ophiopogonins underwent a fast elimination from serum and tissues. There were 10 ginsenosides that could penetrate the blood-brain barrier. In contrast to other saponins, the distributions of S-Rg(2), R-Rg(2), S-Rg(3), R-Rg(3), MD-D and MD-D' in liver were higher than in kidney. Several PPD-type ginsenosides were found to have a long-term accumulation risk in some tissues, especially Rd in kidney. In the excretion study, Rg(1), S-Rg(2) and MD-D were mainly excreted in a prototype and other saponins were mainly e
机译:申迈注射(SMI)是一种中药,已广泛应用于冠状动脉疾病和肿瘤多年来。然而,仍然缺乏对体内SMI行为的深刻研究。在该研究中,开发了可靠,具体和敏感的方法,用于使用液相色谱串联质谱(LC-MS / MS)同时测定SMI中发现的16个皂苷。成功地应用该方法以在单一静脉内施用SMI后探讨6六个活性化合物的药代动力学,组织分布和排泄。这些化合物包括七种蛋白质(PPD型)人参皂甙(人参皂苷RB-1,RB-2,RB-3,RC,RD,S-RG(3),R-RG(3)),六种蛋白质(PPT型) )人参皂甙(非血霉素R-1,人参皂苷,RF,RG(1),S-RG(2),R-RG(2)),一种烯醇酸类人参皂苷(人参皂苷RO)和两种Ophiopogonins(Ophiopogonin D(MD) -d)和ophiopogonin d'(md-d'))。将C-20羟基与糖苷的连接和C-20的手性构型可能会显着影响人参皂苷类体内的药代动力学行为,特别是PPD型人参皂苷。在血清和组织中通常在血清和组织中消除PPD型人参皂苷,但是在C-20携带游离羟基的S / R-RG(3)表现出快速消除,并且R-RG(3)比S-RG更快地消除( 3)。 PPT型人参皂苷,OleAlic酸型人参皂苷和蛋白酶酸型和Ophiopogonins从血清和组织开始快速消除。有10个人参皂苷可以穿透血脑屏障。与其他皂苷相比,肝脏中S-RG(2),R-RG(2),S-RG(3),R-RG(3),MD-D和MD-D'的分布高于在肾脏。发现几种PPD型人参皂苷在某些组织中具有长期积累风险,特别是肾脏中的RD。在排泄研究中,RG(1),S-RG(2)和MD-D主要排出原型,其它皂苷主要是e

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号